EPISODE · Nov 21, 2025 · 3 MIN
Billion To One Skyrockets 15% — The "Google of Diagnostics" or a Post-IPO Bubble?
from Implied Podcast
Billion To One (BLLN) just delivered a massive 15% daily surge, effectively doubling its stock price just weeks after its IPO. Why is Wall Street obsessing over this new biotech player? It comes down to "Molecular Counting"—proprietary tech claiming to be 1,000x more sensitive than standard PCR—and a massive $500 million cash war chest.
Embed this episode
NOW PLAYING
Billion To One Skyrockets 15% — The "Google of Diagnostics" or a Post-IPO Bubble?
0:00
3:00
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Implied Podcast?
This episode is 3 minutes long.
When was this Implied Podcast episode published?
This episode was published on November 21, 2025.
Can I download this Implied Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!